Stay updated on Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a minor build/template update that does not modify study content.
    Difference
    0.1%
    Check dated 2026-07-04T13:23:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.2 instead of v3.6.0, indicating a newer build of the site. This update records the release version displayed for the page.
    Difference
    0.1%
    Check dated 2026-06-27T07:36:47.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record now shows recruitment has ended with a note 'No longer looking for participants.' New help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the Intervention/Treatment label formatting was updated.
    Difference
    0.6%
    Check dated 2026-06-13T05:09:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, indicating a small, non-substantive update to the page.
    Difference
    0.1%
    Check dated 2026-06-05T22:15:45.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend/template update to the page without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-05-15T14:07:28.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The study record was updated to add Janssen Scientific Affairs, LLC as a collaborator and remove the National Cancer Institute (NCI); recent timestamps indicate that the record has been refreshed.
    Difference
    0.3%
    Check dated 2026-05-01T09:10:45.000Z thumbnail image

Stay in the know with updates to Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Relapsed Myeloma Post-Transplant Clinical Trial page.